Pharmaceuticals

Surge In Chronic Pain Prevalence Fueling The Growth Of The Market Due To Rising Cases Of Long-Term Pain Is Supporting Development Across The Oxycodone Hydrochloride Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The Oxycodone Hydrochloride Market Become By 2030 Compared To 2026?

The oxycodone hydrochloride market has demonstrated consistent expansion in recent years. Its valuation is set to increase from $4.32 billion in 2025 to $4.49 billion in 2026, reflecting a compound annual growth rate of 4.0%. Historically, this expansion has been driven by factors including the escalating occurrence of chronic pain conditions, the extensive application of opioids in post-surgical recovery, the scarcity of alternative pain relief methods, firmly established hospital-based prescribing habits, and the availability of proven oral opioid formulations.

The oxycodone hydrochloride market is projected to observe consistent expansion in the coming years, reaching a size of $5.18 billion by 2030, at a compound annual growth rate (CAGR) of 3.6%. This anticipated growth within the forecast period stems from factors such as the development of formulations resistant to abuse and tampering, an increased focus on controlled and regulated opioid usage, the expansion of generic drug manufacturing, a rise in cancer incidence alongside demand for palliative care, and innovation in pain management delivery systems. Significant trends expected during this period include a rising need for effective pain management therapies, increasing adoption of extended-release and abuse-deterrent formulations, a growing number of prescriptions for post-surgical and cancer-related pain, a shift towards generic and cost-effective opioid formulations, and strengthened regulatory oversight combined with controlled distribution.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24646&type=smp

Which Core Factors Are Supporting The Expansion Of The Oxycodone Hydrochloride Market?

The expansion of the oxycodone hydrochloride market is anticipated due to the rising occurrence of chronic pain in the future. Chronic pain, characterized by discomfort lasting at least three months, significantly impacts patients’ quality of life, leading to an increasing need for efficient pain management solutions. An increase in instances of chronic pain largely stems from elements like obesity, an aging demographic, and musculoskeletal issues, all of which contribute to a higher frequency of conditions such as osteoarthritis and lower back pain. Oxycodone hydrochloride aids in managing chronic pain by acting on pain receptors within the nervous system, thereby alleviating moderate-to-severe pain and enhancing patient comfort and everyday activities. As an illustration, data from November 2024, provided by the U.S. National Center for Health Statistics (NCHS), a US- based federal agency, revealed that 24.3% of U.S. adults suffered from chronic pain, with 8.5% reporting high-impact chronic pain, which restricts life or work activities. Consequently, the expanding occurrence of chronic pain is propelling the development of the oxycodone hydrochloride market.

What Are The Core Segment Classifications In The Oxycodone Hydrochloride Market?

The oxycodone hydrochloride market covered in this report is segmented –

1) By Product: Extended Release Tablets, Immediate Release Tablets, Oral Solutions

2) By Route Of Administration: Oral, Parental

3) By Application: Pain Management, Post Surgical Pain, Cancer Related Pain

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Clinics, Homecare

Subsegments:

1) By Extended Release Tablets: Abuse-Deterrent Formulations, Non-Abuse-Deterrent Formulations

2) By Immediate Release Tablets: Combination Products, Single-Agent Formulations

3) By Oral Solutions: Concentrated Solutions, Standard Solutions

Which Trends Are Supporting The Evolution Of The Oxycodone Hydrochloride Market?

Companies operating within the oxycodone hydrochloride market are primarily focused on developing advanced products, such as combination therapies, to improve pain management effectiveness while simultaneously minimizing risks associated with opioid dependency. Combination therapies describe therapeutic approaches that utilize two or more medications or agents together to enhance efficacy, target multiple biological pathways, or decrease the potential for resistance. For instance, in April 2025, Elite Pharmaceuticals Inc., a pharmaceutical company located in the US, introduced a generic form of Percocet (oxycodone hydrochloride and acetaminophen tablets, USP CII). This combination product is commercially available in three strengths: mg/325 mg, 10 mg/325 mg, and 325 mg tablets. It is prescribed for the relief of moderate to moderately severe pain, integrating the opioid oxycodone for powerful pain relief with acetaminophen to boost its analgesic effects. As a Schedule II controlled substance, it holds a substantial potential for abuse and dependence, thereby mandating close medical supervision.

Who Are The Companies Shaping The Oxycodone Hydrochloride Market Landscape?

Major companies operating in the oxycodone hydrochloride market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Lupin Ltd., Mallinckrodt Pharmaceuticals Inc., ANI Pharmaceuticals Inc., Purdue Pharma L.P., Alvogen Inc., Camber Pharmaceuticals, Noramco Inc., Rhodes Pharmaceuticals L.P., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Mylan N.V., Cipla Ltd., Torrent Pharmaceuticals Ltd., Sandoz International GmbH, Pfizer Inc., Novartis AG, Accord Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Fresenius Kabi AG

Access The Complete Oxycodone Hydrochloride Market Report:

https://www.thebusinessresearchcompany.com/report/oxycodone-hydrochloride-global-market-report

Which Region Is The Primary Market For The Oxycodone Hydrochloride Market?

North America was the largest region in the oxycodone hydrochloride market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone hydrochloride market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Oxycodone Hydrochloride Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24646&type=smp

Browse Through More Reports Similar to the Global Oxycodone Hydrochloride Market 2026, By The Business Research Company

Oxycodone Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Hydrochloric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/hydrochloric-acid-global-market-report

Oxalic Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/oxalic-acid-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795